Delivery Order SPE2DB22D1103-SPE2DB25FH2C6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperidone 0.5 mg tablets in a 60-count quantity, with a ceiling value of $1,310.34. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperidone 0.5 mg tablets (60-count) with a firm fixed price ceiling value of $6,580.29. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 4, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999 and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperdal 3 mg tablets (60-count) under a firm fixed-price contract valued at $2,186.98. The delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location....
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for Risperidone 1 mg ODT (orally disintegrating tablet) in unit dose packaging, 30-count quantities. This is a firm fixed-price delivery order with a ceiling value of $1,780.96 and an ultimate completion date of July 22, 2025. The contract is non-set-aside and represents a competitive award. Performance will take place at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $3,953.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Risperdal 2 mg tablets (60-count) on September 9, 2025, with completion targeted for September 10, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,671.44 to AmerisourceBergen Drug Corp for the supply of Risperidone 1 mg ODT (orally disintegrating tablet) in unit dose quantities of 30 tablets. This firm fixed-price, non-set-aside delivery order was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Risperidone is an antipsychotic...
- The Defense Logistics Agency awarded a $12,175.63 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract includes performance through September 11, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract carries no set-aside designation, reflecting the contractor's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Risperidone 1 mg tablets. The contract has a ceiling value of $1,831.49 and a period of performance through March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential ceiling value of $999,999,999.00 and a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,720.64, is for the delivery of risperidone 3 mg tablets over a performance period ending on May 1, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,202.26 by the Defense Logistics Agency on August 15, 2025, for the supply of Risperdal 2 mg tablets (60-count packaging). This firm fixed-price, non-set-aside contract has an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be performed at...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH2C6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperidone 3 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of approximately $2.1K. The award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive delivery order executed through AmerisourceBergen's existing indefinite delivery contract vehicle with DLA. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's DLA Troop Support Medical prime IDV (contract SPE2DX), valued at $999.9M through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare systems worldwide. AmerisourceBergen is one of the largest pharmaceutical distributors supporting federal medical procurement, with an extensive portfolio of generic and brand-name medications, vaccines, and medical supplies delivered to the Defense Health Agency and other federal healthcare entities. The contract structure demonstrates the company's role as a critical vendor within the DLA's medical supply chain, fulfilling routine pharmaceutical requirements through standardized delivery order processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/11/25 |